(Q42656342)

4 November 2017

title

Nonlinear analysis of partial dopamine agonist effects on cAMP in C6 glioma cells (English)

1 reference

4 November 2017

Avalos M

1

1 reference

4 November 2017

Mak C

2

1 reference

4 November 2017

Randall PK

3

1 reference

4 November 2017

Trzeciakowski JP

4

1 reference

4 November 2017

Abell C

5

1 reference

4 November 2017

Kwan SW

6

1 reference

4 November 2017

Wilcox RE

7

1 reference

4 November 2017

publication date

1 January 2001

1 reference

Journal of Pharmacological and Toxicological Methods

4 November 2017

published in

1 reference

4 November 2017

volume

45

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

17-37

1 reference

Receptors and dormant receptors--messengers and opportunistic ligands

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Interactions between effectors linked to serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Cloning and expression of a rat D2 dopamine receptor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Glial cell-specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Agonist-receptor efficacy. II. Agonist trafficking of receptor signals

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Efficacy in drug receptor theory: outdated concept or under-valued tool?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Simple pA2 estimation of partial agonists: Comparison with the kaumann-blinks method

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

A partial agonist model used in the allosteric modulation of the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Review important concepts of receptor theory

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Sensitivity of dopamine D2 receptors following long-term treatment with roxindole

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Dopamine Auto- and Postsynaptic Receptors: Electrophysiological Evidence for Differential Sensitivity to Dopamine Agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Single apomorphine pretreatment results in a rapid decline in high-affinity dopamine binding to the striatal dopamine D-2 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

A method for normalizing drug responses to enhance reliability of parametric statistical tests

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Stimulus amplification, efficacy, and the operational model. Part I--binary complex occupancy mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Stimulus amplification, efficacy, and the operational model. Part II--ternary complex occupancy mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Behavioral sensitization following a single apomorphine pretreatment--selective effects on the dopamine release process.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2801%2900118-6

7 January 2021

10.1016/S1056-8719(01)00118-6

Identifiers

DOI

1 reference

4 November 2017

1 reference